Customized 3D printed multi-drug systems: an effective and efficient approach to polypharmacy

References

• Gradman AH, Basile JN, Carter BL, et al. Combination therapy in hypertension. J. Am. Soc.Hypertens. 2010;4(1):42–50.
   PubMed Web of Science ®Google Scholar
• Cruz AT, Garcia-Prats AJ, Furin J, et al. Treatment of multidrug-resistant tuberculosis infection in children. Pediatr Infect Dis J. 2018;37(8):831–834.
   PubMed Web of Science ®Google Scholar
• Weverling GJ, Lange JM, Jurriaans S, et al. Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. AIDS. 1998;12(11):F117–22.
   PubMed Web of Science ®Google Scholar
• Standard Treatment Guidelines And Essential Medicines List For South Africa Hospital Level 2015 Edition. 2015.
   Google Scholar
• Payne RA, Avery AJ.Polypharmacy: one of the greatest prescribing challenges in general practice.Br. J. Gen. Pract. J. R. Coll. Gen. Pract.2011;61:83–84. 583
   PubMed Web of Science ®Google Scholar
• Nakajima R, Watanabe F, Kamei M. Factors associated with medication non-adherence among patients with lifestyle-related non-communicable diseases. Pharmacy. 2021;9(90):1–11.
   Google Scholar
• González-Bueno J, Sevilla-Sánchez D, Puigoriol-Juvanteny E, et al. Factors associated with medication non-adherence among patients with multimorbidity and polypharmacy admitted to an intermediate care center. Int J Environ Res Public Health. 2021 Sep;18(18):9606.
   PubMed Web of Science ®Google Scholar
• Butler RJ, Davis TK, Johnson WG, et al. Effects of nonadherence with prescription drugs among older adults. Am J Manag Care. 2011;17(2):153–160.
   PubMed Web of Science ®Google Scholar
• Abushouk AI, Sayed A, Munir M, et al. Fixed-Dose combination (polypill) for cardiovascular disease prevention: a meta-analysis. Am J Prev Med. 2022 [Cited 2021 Sep 28];[00185–4]. 10.1016/j.amepre.2022.03.027
   PubMedGoogle Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representat. Eur Heart J. 2016;37(29):2315–2381.
   PubMed Web of Science ®Google Scholar
• WHO. HEARTS technical package for cardiovascular disease management in primary health care. [Internet]. 2016. cited 2021 Sep 29]. Available from: http://www.who.int/cardiovascular_diseases/hearts/Hearts_package.pdf
   Google Scholar
• Yusuf S, Pais P, Afzal R, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet. 2009;373(9672):1341–1351.
   PubMed Web of Science ®Google Scholar
• Webster R, Castellano JM, Onuma OK. Polypills 2 putting polypills into practice : challenges and lessons learned. Lancet. 2017;389(10073):1066–1074.
   PubMed Web of Science ®Google Scholar
• Jamróz W, Szafraniec J, Kurek M, et al., 3D printing in pharmaceutical and medical applications – recent achievements and challenges. Pharm Res. 2018;35(9): 176.
   PubMed Web of Science ®Google Scholar
• Mahmood A, Singhvi G, Manchanda P, et al. Applications of 3D printing for the advancement of oral dosage forms. In: du Toit LC, Kumar P, Choonara YE, et al.editors. Advanced 3D-Printed systems and nanosystems for drug delivery and tissue engineering. Duxford: Woodhead Publishing; 2020. p. 39–59.
   Google Scholar
• Abdulhameed O, Al-ahmari A, Ameen W, et al. Additive manufacturing : challenges, trends, and applications. Adv Mech Eng. 2019;11(2):1–27.
   Web of Science ®Google Scholar
• Choonara YE, Toit LC, Kumar P, et al. 3D-printing and the effect on medical costs : a new era ? Expert Rev Pharmacoecon Outcomes Res. 2016;16(1):23–32.
   PubMed Web of Science ®Google Scholar
• Zhu X, Li H, Huang L, et al. Biomedicine & Pharmacotherapy 3D printing promotes the development of drugs. Biomed Pharmacother. 2020;131:110644.
   PubMed Web of Science ®Google Scholar
• Horst DJ. 3D printing of pharmaceutical drug delivery systems. Arch Org Inorg Chem Sci. 2018;1(2):3–8.
   Google Scholar
• Goyanes A, Wang J, Buanz A, et al., 3D printing of medicines : engineering novel oral devices with unique design and drug release characteristics. Mol Pharm. 2015;12(11): 4077–4084.
   PubMed Web of Science ®Google Scholar
• Awad A, Tren SJ, Gaisford S, et al. 3D printed medicines : a new branch of digital healthcare.International. J Pharm (Cairo). 2018;548(1):586–596.
   PubMed Web of Science ®Google Scholar
• Bloomquist CJ, Mecham MB, Paradzinsky MD, et al. Controlling release from 3D printed medical devices using CLIP and drug-loaded liquid resins. J Control Release. 2018;278:9–23.
   PubMed Web of Science ®Google Scholar
• Lim SH, Ng JY, Kang L. Three-dimensional printing of a microneedle array on personalized curved surfaces for dual-pronged treatment of trigger finger. Biofabrication. 2017;9(1):15010.
   Web of Science ®Google Scholar
• Kadry H, Wadnap S, Xu C, et al. Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets. Eur J Pharm Sci. 2019;135:60–67.
   PubMed Web of Science ®Google Scholar
• Alhnan MA, Okwuosa TC, Sadia M, et al. Emergence of 3D printed dosage forms : opportunities and challenges. Pharm Res. 2016;33(8):1817–1832.
   PubMed Web of Science ®Google Scholar
• Gioumouxouzis CI, Baklavaridis A, Katsamenis OL, et al. European Journal of Pharmaceutical Sciences. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. Eur J Pharm Sci. 2018;120:40–52.
   PubMed Web of Science ®Google Scholar
• Robles-martinez P, Xu X, Trenfield SJ, et al. 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics. 2019;11(6):274.
   Web of Science ®Google Scholar
• Andreadis II, Gioumouxouzis CI, Eleftheriadis GK, et al. The advent of a new era in digital healthcare: a role for 3d printing technologies in drug manufacturing? Pharmaceutics. 2022;14(3):609.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis GK, Fatouros DG. Haptic Evaluation of 3D-printed Braille-encoded intraoral films. Eur J Pharm Sci. 2021;157:105605.
   PubMed Web of Science ®Google Scholar
• Rycerz K, Stepien KA, Czapiewska M, et al. Embedded 3D printing of novel bespoke soft dosage form concept for pediatrics. Pharmaceutics. 2019;11(12):630.
   Web of Science ®Google Scholar
• Eduardo D-T, Ana S-E, José BF. A micro-extrusion 3D printing platform for fabrication of orodispersible printlets for pediatric use. Int J Pharm. 2021;605:120854.
   PubMedGoogle Scholar
• Karavasili C, Gkaragkounis A, Moschakis T, et al. Pediatric-friendly chocolate-based dosage forms for the oral administration of both hydrophilic and lipophilic drugs fabricated with extrusion-based 3D printing. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2020;147:105291.
   PubMed Web of Science ®Google Scholar
• Kassem T, Sarkar T, Nguyen T. 3D printing in solid dosage forms and organ-on-chip applications. Biosensors. 2022;12(4):186
   PubMedGoogle Scholar
• Khaled SA, Burley JC, Alexander MR, et al. 3D printing of tablets containing multiple drugs with defined release profiles. Int j pharm. 2015;494(2):643–650.
   PubMed Web of Science ®Google Scholar
• Siyawamwaya M, Toit LC, Kumar P, et al. European journal of pharmaceutics and biopharmaceutics 3D printed, controlled release, tritherapeutic tablet matrix for advanced anti-HIV-1 drug delivery. Eur J Pharm Biopharm. 2019;138:99–110.
   PubMedGoogle Scholar
• Domsta V, Seidlitz A. 3D-Printing of drug-eluting implants : an overview of the current developments described in the literature. Molecules. 2021;26(13):4066.
   PubMed Web of Science ®Google Scholar
• Genina N, Boetker JP, Colombo S, et al. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms : from drug product design to in vivo testing. J Control Release. 2017;268(10):40–48.
   PubMedGoogle Scholar
• Xu X, Robles-martinez P, Madla CM, et al. Stereolithography (SLA) 3D printing of an antihypertensive polyprintlet : case study of an unexpected photopolymer-drug reaction. Addit Manuf. 2020;33(12):101071.
   Google Scholar
• Long J, Gholizadeh H, Lu J, et al. Application of Fused Deposition Modelling (FDM) method of 3D printing in drug delivery. Curr Pharm Des. 2017;23(3):433–439.
   PubMed Web of Science ®Google Scholar
• Repka MA, Bandari S, Kallakunta VR, et al. Melt extrusion with poorly soluble drugs – an integrated review. Int J Pharm. 2018;535(1–2):68–85.
   PubMedGoogle Scholar
• Lubrizol Corporation. Hot melt extrusion, life science. Cleveland. 2019;1620:1–5.
   Google Scholar
• Zhang J, Feng X, Patil H, et al. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm. 2017;519(1–2):186–197.
   PubMed Web of Science ®Google Scholar
• Thanawuth K, Sutthapitaksakul L, Konthong S, et al. Impact of drug loading method on drug release from 3D-printed tablets made from filaments fabricated by hot-melt extrusion and impregnation processes. Pharmaceutics. 2021;13(10):1607.
   PubMed Web of Science ®Google Scholar
• Wesholowski J, Hoppe K, Nickel K, et al. European Journal of Pharmaceutics and Biopharmaceutics scale-up of pharmaceutical hot-melt-extrusion : process optimization and transfer. Eur J Pharm Biopharm . 2019;142(1):396–404.
   PubMedGoogle Scholar
• Andrews GP, Jones DS, Senta-Loys Z, et al. The development of an inline Raman spectroscopic analysis method as a quality control tool for hot melt extruded ramipril fixed-dose combination products. Int J Pharm. 2019;566:476–487.
   PubMedGoogle Scholar
• Ponsar H, Wiedey R, Quodbach J. Hot-Melt extrusion process fluctuations and their impact on critical quality attributes of filaments and 3D-printed dosage forms. Pharmaceutics. 2020;12(6):511.
   Web of Science ®Google Scholar
• Yang Z, Jin L, Yan Y, et al. Filament breakage monitoring in fused deposition modeling using acoustic emission technique. Sensors . 2018;18.
   Web of Science ®Google Scholar
• Hagrasy AS, Cruise P, Jones I, et al. In-line size monitoring of a twin screw granulation process using high-speed imaging. J Pharm Innov. 2013;8(2):90–98.
   Web of Science ®Google Scholar
• Korte C, Quodbach J. Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines. Pharm Dev Technol. 2018;23(10):1117–1127.
   PubMed Web of Science ®Google Scholar
• Aulton ME, Taylor K. Aulton’s pharmaceutics : the design and manufacture of medicines LK. 4th ed. TA - TT -. Edinburgh SE - xiii, 894  Churchill Livingstone/Elsevier; 2013. Available from. http://www.dawsonera.com/depp/reader/protected/external/AbstractView/S9780702053931
   Google Scholar
• Hwang Y-C, Kang M, Ahn CW, et al. Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes. Int J Clin Pract. 2013;67(3):236–243.
   PubMed Web of Science ®Google Scholar
• Windolf H, Chamberlain R, Breitkreutz J, et al., 3D printed mini-floating-Polypill for Parkinson’s disease: combination of levodopa, benserazide, and pramipexole in various dosing for personalized therapy. Pharmaceutics . 2022;14(5): 931.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Deng F, Wang B, et al. Melt extrusion deposition (MEDTM) 3D printing technology – a paradigm shift in design and development of modified release drug products. Int J Pharm. 2021;602:120639.
   PubMedGoogle Scholar
• Azad MA, Olawuni D, Kimbell G, et al. Polymers for extrusion-based 3D printing of pharmaceuticals : a holistic materials – process perspective. Pharmaceutics. 2020;12(2):124.
   PubMed Web of Science ®Google Scholar
• Shahi SR, Zadbuke NS, Gulecha B, et al. Design and development of controlled porosity osmotic tablet of diltiazem hydrochloride. J Adv Pharm Technol Res. 2012;3(4):229–236.
   PubMedGoogle Scholar
• Sahoo CK, Kanta Sahoo N, Rao SRM, et al. A review on controlled porosity osmotic pump tablets and its evaluation. Bull Fac Pharmacy, Cairo Univ. 2015;53(2):195–205.
   Google Scholar
• Melchels FPW, Feijen J, Grijpma DW. Biomaterials. A review on stereolithography and its applications in biomedical engineering. Biomaterials. 2010;31(24):6121–6130.
   PubMed Web of Science ®Google Scholar
• Abaci A, Gedeon C, Kuna A, et al. Additive manufacturing of oral tablets : technologies, materials and printed tablets. Pharmaceutics. 2021;31(156): 1–27
   Google Scholar
• Pereira BC, Isreb A, Forbes RT, et al. European Journal of Pharmaceutics and Biopharmaceutics ‘ temporary plasticiser ’: a novel solution to fabricate 3d printed patient- centred cardiovascular ‘ polypill ’ architectures. Eur J Pharm Biopharm. 2019;135(12):94–103.
   PubMedGoogle Scholar
• Sharma PK, Choudhury D, Yadav V, et al. 3D printing of nanocomposite pills through desktop vat photopolymerization (stereolithography) for drug delivery reasons. 3D Print Med. 2022;8(30):1–10.
   PubMedGoogle Scholar
• Awad A, Fina F, Trenfield SJ, et al. 3D printed pellets (miniprintlets): a novel, multi-drug, controlled release platform technology. Pharmaceutics. 2019;11(4):148.
   Web of Science ®Google Scholar
• Khaled SA, Burley JC, Alexander MR, et al. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release. 2015;217:308–314.
   PubMed Web of Science ®Google Scholar
• Gbureck U, Vorndran E, Müller FA, et al. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Control Release. 2007;122(2):173–180.
   PubMed Web of Science ®Google Scholar
• Wu W, Zheng Q, Guo X, et al. The controlled-releasing drug implant based on the three dimensional printing technology: fabrication and properties of. J Wuhan Univ Technol Sci Ed. 2009;24(6):977–981.
   Web of Science ®Google Scholar
• Wu W, Zheng Q, Guo X, et al. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis. Biomed Mater. 2009;4(6):065005.
   PubMed Web of Science ®Google Scholar
• Wu W, Ye C, Zheng Q, et al. A therapeutic delivery system for chronic osteomyelitis via a multi-drug implant based on three-dimensional printing technology. J Biomater Appl. 2016;31(2):250–260.
   PubMed Web of Science ®Google Scholar
• Vorndran E, Klammert U, Ewald A, et al. Simultaneous immobilization of bioactives during 3D powder printing of bioceramic drug release matrices. Adv Funct Mater. 2010;20(10):1585–1591.
   Web of Science ®Google Scholar
• Zhu M, Li K, Zhu Y, et al. 3D-printed hierarchical scaffold for localized isoniazid/rifampin drug delivery and osteoarticular tuberculosis therapy. Acta Biomater. 2015;16:145–155.
   PubMed Web of Science ®Google Scholar
• Li K, Zhu M, Xu P, et al. Three-dimensionally plotted MBG/PHBHHx composite scaffold for antitubercular drug delivery and tissue regeneration. J Mater Sci Mater Med. 2015;26(2):102.
   PubMed Web of Science ®Google Scholar
• Inzana JA, Trombetta RP, Schwarz EM, et al. 3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection. Eur Cell Mater. 2015;30:232–247.
   PubMed Web of Science ®Google Scholar
• Trombetta RP, Ninomiya MJ, El-Atawneh IM, et al. Calcium phosphate spacers for the local delivery of sitafloxacin and rifampin to treat orthopedic infections: efficacy and proof of concept in a mouse model of single-stage revision of device-associated osteomyelitis. Pharmaceutics. 2019;11(2):94.
   PubMed Web of Science ®Google Scholar
• Chou PY, Chou YC, Lai YH, et al. Fabrication of drug-eluting nano-hydroxylapatite filled polycaprolactone nanocomposites using solution-extrusion 3d printing technique. Polymers (Basel). 2021;13(3):1–13.
   Web of Science ®Google Scholar
• Boyer CJ, Ballard DH, Weisman JA, et al. Three-dimensional printing antimicrobial and radiopaque constructs. 3D Print Addit Manuf. 2018;5(1):29–35.
   PubMedGoogle Scholar
• Poudel I, Annaji M, Arnold RD, et al. Dexamethasone eluting 3D printed metal devices for bone injuries. Ther Deliv. 2020;11(6):373–386.
   PubMed Web of Science ®Google Scholar
• Boyer CJ, Woerner JE, Galea C, et al. Personalized bioactive nasal supports for postoperative cleft rhinoplasty. J Oral Maxillofac Surg off J Am Assoc Oral Maxillofac Surg. 2018;76(7):1562.e1–1562.e5.
   Google Scholar
• Ngo TT, Hoffman L, Hoople GD, et al. Surface morphology and drug loading characterization of 3D-printed methacrylate-based polymer facilitated by supercritical carbon dioxide. J Supercrit Fluids Internet]. 2020;160:104786. Available from.;.:https://www.sciencedirect.com/science/article/pii/S0896844620300371
   Web of Science ®Google Scholar
• Stewart SA, Domínguez-Robles J, McIlorum VJ, et al. Development of a biodegradable subcutaneous implant for prolonged drug delivery using 3D printing. Pharmaceutics. 2020;12(2):105.
   PubMed Web of Science ®Google Scholar
• Stewart SA, Domínguez-Robles J, McIlorum VJ, et al. Poly(caprolactone)-based coatings on 3D-Printed biodegradable implants: a novel strategy to prolong delivery of hydrophilic drugs. Mol Pharm. 2020;17(9):3487–3500.
   PubMedGoogle Scholar
• Arany P, Papp I, Zichar M, et al. In vitro tests of FDM 3D-printed diclofenac sodium-containing implants. Molecules . 2020;25.
   Web of Science ®Google Scholar
• Weisman JA, Ballard DH, Jammalamadaka U, et al. 3D printed antibiotic and chemotherapeutic eluting catheters for potential use in interventional radiology: in vitro proof of concept study. Acad Radiol. 2019;26(2):270–274.
   PubMed Web of Science ®Google Scholar
• Pugliese R, Beltrami B, Regondi S, et al. Annals of 3D printed medicine polymeric biomaterials for 3D printing in medicine : an overview. Ann 3D Print Med. 2021; 2: 100011.
   Google Scholar
• Jain A, Bansal KK, Tiwari A, et al. Role of polymers in 3D printing technology for drug delivery - an overview role of polymers in 3d printing technology for drug delivery - an overview. Curr Pharm Des. 2018;24:4979–4990.
   PubMed Web of Science ®Google Scholar
• Healy AV, Fuenmayor E, Doran P, et al. Additive manufacturing of personalized pharmaceutical dosage forms via stereolithography. Pharmaceutics. 2019;11(645):1–20.
   Google Scholar
• Stansbury JW, Idacavage MJ. 3D printing with polymers: challenges among expanding options and opportunities. Dent Mater. 2016;32(1):54–64.
   PubMed Web of Science ®Google Scholar
• Gross BC, Erkal JL, Lockwood SY, et al. Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences. Anal Chem. 2014;86(7):3240–3253.
   PubMed Web of Science ®Google Scholar
• Ligon SC, Liska R, Stampfl J, et al. Polymers for 3D printing and customized additive manufacturing. Chem Rev. 2017;117(15):10212–10290.
   PubMed Web of Science ®Google Scholar
• Raj B, Surendra G, Dong P, et al. Cellulose and its derivatives for application in 3D printing of pharmaceuticals. J Pharm Investig. 2021;51(1):1–22.
   Web of Science ®Google Scholar
• Siyawamwaya M, Choonara YE, Kondiah PPD, et al. International Journal of Polymeric Materials and a humic acid-polyquaternium-10 stoichiometric self-assembled fibrilla polyelectrolyte complex : effect of pH on synthesis, characterization, and drug release. Int J Polym Mater Polym Biomater. 2017;65(11):550–560.
   Web of Science ®Google Scholar
• Langer R, Basu A, Domb AJ. Special issue: polylactide (PLA) based biopolymers. Adv Drug Del Rev Netherlands. 2016;107:1–2.
   PubMed Web of Science ®Google Scholar
• Evonik Eudragit®setting benchmarks in oral solid dosage forms since 1954.[Internet]. 2021 [cited on 2021 Sep 15]. Available from: https://healthcare.evonik.com/sites/lists/NC/DocumentsHC/EvonikEudragit_brochure
   Google Scholar
• Thakral S, Thakral NK, Majumdar DK. Eudragit: a technology evaluation. Expert Opin Drug Deliv. 2013;10(1):131–149.
   PubMed Web of Science ®Google Scholar
• Okwuosa TC, Pereira BC, Arafat B, et al. Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centred therapy. Pharm Res. 2017;34(2):427–437.
   PubMed Web of Science ®Google Scholar
• Kempin W, Domsta V, Grathoff G, et al. Immediate release 3D-printed tablets produced via fused deposition modeling of a thermo-sensitive drug. Pharm Res. 2018;35(6):124.
   PubMed Web of Science ®Google Scholar
• Shaqour B, Samaro A, Verleije B, et al. Production of drug delivery systems using fused filament fabrication: a systematic review. Pharmaceutics . 2020;12(6):517.
   Web of Science ®Google Scholar
• Beamler Additive Manufacturing. High performance materials for 3D printing. In Materials, May 29 2020. [Internet]. Netherlands; [Updated Jun 9th, 2021 cited 2021 cited 2021 Sept 9th, 2021]. Available from: https://www.beamler.com/high-performance-materials-for-3d-printing/
   Google Scholar
• Kang J, Zhang J, Zheng J, et al. 3D-printed PEEK implant for mandibular defects repair - a new method. J Mech Behav Biomed Mater. 2021 Apr;116:104335.
   PubMed Web of Science ®Google Scholar
• Gu X, Sun X, Sun Y, et al. Bioinspired modifications of PEEK implants for bone tissue engineering. Front Bioeng Biotechnol. 2021;8(1):616–631.
   Google Scholar
• GlobalData Healthcare. Medical Device Network, 3D printing of drugs can revolutionise personalised medicine and improve sustainability by [Internet]. New York; [Updated February 4th, 2021 17:27 cited 2021 Sept 215]. Available from: https://www.medicaldevice-network.com/comment/3d-printing-drugs-personalised-medicine-sustainability/
   Google Scholar
• Reddy VC, B V, Venkatesh MP, et al. First FDA approved 3D printed drug paved new path for increased precision in patient care. App Clin Res Clin Trials Regul Aff Bentham Sci. 2020;7(2):93–103.
   Google Scholar
• Bhusnure OG, Gholve SV, Sugave BK, et al. 3D printing & pharmaceutical manufacturing : opportunities and challenges 3D printing & pharmaceutical manufacturing : opportunities and challenges. Int J Bioassays. 2016;5(1):4723–4738.
   Google Scholar
• Basit AW, Trenfield SJ 3D printing of pharmaceuticals and the role of pharmacy. Drug discovery and development .The Pharmaceutical Journal. [Internet]. 2022 [cited 2021 Aug 25]. Available from: https://pharmaceutical-journal.com/article/research/3d-printing-of-pharmaceuticals-and-the-role-of-pharmacy
   Google Scholar
• Shahrubudin N, Koshy P, Alipal J, et al. Heliyon challenges of 3D printing technology for manufacturing biomedical products : a case study of Malaysian manufacturing firms. Heliyon. 2020;6(3):e03734.
   PubMedGoogle Scholar
• Safi S, Thiessen T, Schmailzl KJ. Acceptance and resistance of new digital technologies in medicine: qualitative study. JMIR Res Protoc. 2018;7(12):e11072.
   PubMed Web of Science ®Google Scholar
• Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet. 2006;368(9536):679–686.
   PubMed Web of Science ®Google Scholar
• van Gils PF, Over EAB, Hamberg-van Reenen HH, et al. The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population. BMJ Open. 2011;1(2):e000363.
   PubMed Web of Science ®Google Scholar
• López-Jaramillo P, González-Gómez S, Zarate-Bernal D, et al., Polypill: an affordable strategy for cardiovascular disease prevention in low-medium-income countries. Ther Adv Cardiovasc Dis. 2018;12(6): 169–174.
   PubMedGoogle Scholar
• Vos T, Carter R, Barendregt J Assessing the Cost-Effectiveness of Prevention (ACE-Prevention): final report [Internet] University of Queensland, Brisbane and Deakin University, Melbourne; 2010 [cited 2021 Oct 2]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24521531
   Google Scholar
• Banks J. Adding value in additive manufacturing : researchers in the United Kingdom and Europe look to 3D printing for customization. IEEE Pulse. 2013;4(6):22–26. cited 2021 Sept 25.
   PubMed Web of Science ®Google Scholar
• Ventola CL. Medical applications for 3D printing : current and projected uses. P&t. 2014;39(10):704–711.
   PubMedGoogle Scholar
• 3D printing for healthcare market report 2021-2031. SWOT analysis. Published: [Updated 2021 Jul 27 cited 2021 Sept 25]. Available from:https://www.visiongain.com/report/3d-printing-for-healthcare-market-2021/#download sampe_div
   Google Scholar
• Press release. Healthcare 3D printing market size 2021 report offers opportunities, challenges, risks and influences factors analysis, industry trends. Friday. 2021 Jul 30;4:54. AM CDT. [Updated 27 July 2021 cited 2021 Sept 21] Available from https://www.newschannelnebraska.com/story/44418826/healthcare-3d-printing-market-size-2021-report-offers-opportunities-challenges-risks-and-influences-factors-analysis.
   Google Scholar
• Id TE, Abualsamen MM, Almomani BA, et al. Acceptance and attitudes toward COVID-19 vaccines : a cross-sectional study from Jordan. PLoS ONE. 2021;16(816):1–15.
   Google Scholar
• Dvoretskaya A The uses and prospects for 3D printing in pharmacology. European pharmaceutical review. [Internet]. Kent, TN16 1NU United Kingdom [cited 2021 Aug 25]. Available from: https://www.europeanpharmaceuticalreview.com/article/119865/the-uses-and-prospects-for-3d-printing-in-pharmacology/
   Google Scholar
• Varghese R, Salvi S, Sood P, et al. 3D printed medicine for the management of chronic diseases: the road less travelled. Ann 3D Print Med. 2022; 5: 100043.
   Google Scholar
• FabRx.[Internet].UK 2021 [cited 2022 Jun 10]. Available from: https://www.fabrx.co.uk/technologies/
   Google Scholar
• Algahtani MS. Assessment of pharmacist’s knowledge and perception toward 3D printing technology as a dispensing method for personalized medicine and the readiness for implementation. Pharmacy. 2021;9(68):1–14.
   Google Scholar
• National Library of Medicine.[Internet]. USA 2021 [cited 2021 Sep 21]. Available from:https://pubmed.ncbi.nlm.nih.gov/?term=3d+printing
   Google Scholar
• Trenfield SJ, Awad A, Goyanes A, et al. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol Sci. 2018 May;39(5):440–451.
   PubMed Web of Science ®Google Scholar
• Beitler BG, Abraham PF, Glennon AR, et al. Interpretation of regulatory factors for 3D printing at hospitals and medical centers, or at the point of care. 3D Print Med. 2022;8(7):1–7.
   PubMedGoogle Scholar
• National Library of Medicine. [Internet]. [Cited 2021 Oct 1]. Available from: https://clinicaltrials.gov/ct2/home
   Google Scholar
• du Toit LC, Kumar P, Choonara YE, et al. 4D printing and beyond: where to from here? In: du Toit LC, Kumar P, Choonara YE, et al.editors. Advanced 3d-Printed systems and nanosystems for drug delivery and tissue engineering. Duxford: Woodhead Publis; 2020. p. 2020.
   Google Scholar
• Lukin I, Musquiz S, Erezuma I, et al. Expert opinion on drug discovery can 4D bioprinting revolutionize drug development? Expert Opin Drug Discov. 2019;14(10):953–956.
   PubMed Web of Science ®Google Scholar